Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

Summary

RATIONALE: Current therapies for childhood Rhabdoid tumors provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood Rhabdoid tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) with Rhabdoid tumors.

Timeline

Start

1996-02

Primary completion

2003-05

Completion

2003-05

Drugs

Indications